Reflections on the Innovative Medicines Initiative

被引：0
|
作者：
Michel Goldman
机构：
[1] Michel Goldman is Executive Director of the Innovative Medicines Initiative,
[2] B-1060 Brussels,undefined
[3] Belgium.,undefined
来源：
Nature Reviews Drug Discovery | 2011年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public–private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
引用
收藏
页码：321 / 322
页数：1
相关论文
共 50 条
  • [1] Reflections on the Innovative Medicines Initiative
    Goldman, Michel
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) : 321 - 322
  • [2] Erratum: Reflections on the Innovative Medicines Initiative
    Michel Goldman
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 471 - 471
  • [3] Will the Innovative Medicines Initiative really deliver innovative medicines?
    Wilkinson, Emma
    [J]. MOLECULAR ONCOLOGY, 2008, 2 (03) : 203 - 205
  • [4] Reflections on the Innovative Medicines Initiative (vol 10, pg 321, 2011)
    Goldman, Michel
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) : 475 - 475
  • [5] INNOVATIVE MEDICINES INITIATIVE: THE SPRINTT PROJECT
    Marzetti, E.
    Calvani, R.
    Landi, F.
    Hoogendijk, E.
    Fougere, B.
    Vellas, B.
    Pahor, M.
    Bernabei, R.
    Cesari, M.
    [J]. JOURNAL OF FRAILTY & AGING, 2015, 4 (04): : 207 - 208
  • [6] Innovative Medicines Initiative and antibiotic resistance
    Kostyanev, Tarnishiv
    Bonten, Marc J. M.
    O'Brien, Seamus
    Goossens, Herman
    [J]. LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1373 - 1375
  • [7] Benchmarking the scientific output of the Innovative Medicines Initiative
    Gunn, Magda
    Lim, Mark
    Cross, Didi
    Goldman, Michel
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (08) : 811 - 812
  • [8] The Innovative Medicines Initiative: an engine for regulatory science
    Michel Goldman
    Nathalie Seigneuret
    Hans-Georg Eichler
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 1 - 2
  • [9] The European Innovative Medicines Initiative: Progress to Date
    Faure J.-E.
    Dyląg T.
    Norstedt I.
    Matthiessen L.
    [J]. Pharmaceutical Medicine, 2018, 32 (4) : 243 - 249
  • [10] Impact of the Innovative Medicines Initiative on vaccine development
    Philippe Denoel
    Patricia Londoño-Hayes
    Magda Chlebus
    Magdalena Rodriguez de Azero
    [J]. Nature Reviews Drug Discovery, 2018, 17 : 769 - 770
12345